{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T19:45:29Z","timestamp":1790451929844,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100011102","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["317250"],"award-info":[{"award-number":["317250"]}],"id":[{"id":"10.13039\/100011102","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.ejps.2018.06.018","type":"journal-article","created":{"date-parts":[[2018,6,20]],"date-time":"2018-06-20T01:26:33Z","timestamp":1529457993000},"page":"77-84","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Pharmacokinetics of pericyte involvement in small-molecular drug transport across the blood-brain barrier"],"prefix":"10.1016","volume":"122","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3024-405X","authenticated-orcid":false,"given":"Nebojsa","family":"Mihajlica","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christer","family":"Betsholtz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9181-1321","authenticated-orcid":false,"given":"Margareta","family":"Hammarlund-Udenaes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2018.06.018_bb0005","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s10545-013-9608-0","article-title":"Blood\u2013brain barrier structure and function and the challenges for CNS drug delivery","volume":"36","author":"Abbott","year":"2013","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ejps.2018.06.018_bb0010","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrn1824","article-title":"Astrocyte-endothelial interactions at the blood\u2013brain barrier","volume":"7","author":"Abbott","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ejps.2018.06.018_bb0015","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1161\/01.RES.0000182903.16652.d7","article-title":"Endothelial\/pericyte interactions","volume":"97","author":"Armulik","year":"2005","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejps.2018.06.018_bb0020","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nature09522","article-title":"Pericytes regulate the blood\u2013brain barrier","volume":"468","author":"Armulik","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.ejps.2018.06.018_bb0025","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.devcel.2011.07.001","article-title":"Pericytes: developmental, physiological, and pathological perspectives, problems, and promises","volume":"21","author":"Armulik","year":"2011","journal-title":"Dev. Cell"},{"key":"10.1016\/j.ejps.2018.06.018_bb0030","doi-asserted-by":"crossref","first-page":"419","DOI":"10.4155\/tde.11.23","article-title":"Pericytes and the blood\u2013brain barrier: recent advances and implications for the delivery of CNS therapy","volume":"2","author":"Armulik","year":"2011","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.ejps.2018.06.018_bb0035","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1002\/jps.10332","article-title":"Development and validation of a 96-well equilibrium dialysis apparatus for measuring plasma protein binding","volume":"92","author":"Banker","year":"2003","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2018.06.018_bb0040","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.neuron.2010.09.043","article-title":"Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging","volume":"68","author":"Bell","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.ejps.2018.06.018_bb0045","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1067\/mcp.2002.121829","article-title":"Changes in plasma protein binding have little clinical relevance","volume":"71","author":"Benet","year":"2002","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2018.06.018_bb0050","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1002\/jps.23614","article-title":"Plasma protein binding: from discovery to development","volume":"102","author":"Bohnert","year":"2013","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2018.06.018_bb0055","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1124\/dmd.106.009746","article-title":"In vivo blood\u2013brain barrier transport of oxycodone in the rat: indications for active influx and implications for pharmacokinetics\/pharmacodynamics","volume":"34","author":"Bostrom","year":"2006","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2018.06.018_bb0060","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1007\/s10072-013-1290-3","article-title":"Somatic comorbidities and Alzheimer's disease treatment","volume":"34","author":"Clodomiro","year":"2013","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.ejps.2018.06.018_bb0065","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/nature09513","article-title":"Pericytes are required for blood\u2013brain barrier integrity during embryogenesis","volume":"468","author":"Daneman","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.ejps.2018.06.018_bb0070","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1172\/JCI114279","article-title":"Plasma binding and transport of diazepam across the blood\u2013brain barrier. No evidence for in vivo enhanced dissociation","volume":"84","author":"Dubey","year":"1989","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejps.2018.06.018_bb0075","doi-asserted-by":"crossref","first-page":"6233","DOI":"10.1021\/jm901036q","article-title":"Structure-brain exposure relationships in rat and human using a novel data set of unbound drug concentrations in brain interstitial and cerebrospinal fluids","volume":"52","author":"Friden","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejps.2018.06.018_bb0080","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/clpt.2013.175","article-title":"Profiling solute carrier transporters in the human blood\u2013brain barrier","volume":"94","author":"Geier","year":"2013","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2018.06.018_bb0085","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1038\/nm.2052","article-title":"Activation of PKC-delta and SHP-1 by hyperglycemia causes vascular cell apoptosis and diabetic retinopathy","volume":"15","author":"Geraldes","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejps.2018.06.018_bb0090","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1002\/ana.24512","article-title":"Pericytes are involved in the pathogenesis of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy","volume":"78","author":"Ghosh","year":"2015","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ejps.2018.06.018_bb0095","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1007\/s11095-007-9502-2","article-title":"On the rate and extent of drug delivery to the brain","volume":"25","author":"Hammarlund-Udenaes","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2018.06.018_bb0100","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s40266-016-0415-9","article-title":"Risk factors for initiation of potentially inappropriate medications in community-dwelling older adults with and without Alzheimer's disease","volume":"34","author":"Hyttinen","year":"2017","journal-title":"Drugs Aging"},{"key":"10.1016\/j.ejps.2018.06.018_bb0105","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/bdd.325","article-title":"Influence of nonspecific brain and plasma binding on CNS exposure: implications for rational drug discovery","volume":"23","author":"Kalvass","year":"2002","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.ejps.2018.06.018_bb0110","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.nbd.2012.12.007","article-title":"Blood\u2013brain barrier opening to large molecules does not imply blood\u2013brain barrier opening to small ions","volume":"52","author":"Kang","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ejps.2018.06.018_bb0115","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1177\/0271678X15606459","article-title":"Regulation of P-glycoprotein expression in brain capillaries in Huntington's disease and its impact on brain availability of antipsychotic agents risperidone and paliperidone","volume":"36","author":"Kao","year":"2016","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.ejps.2018.06.018_bb0120","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.neuron.2014.03.003","article-title":"Stepwise recruitment of transcellular and paracellular pathways underlies blood\u2013brain barrier breakdown in stroke","volume":"82","author":"Knowland","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.ejps.2018.06.018_bb0125","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nrd4626","article-title":"SLC transporters as therapeutic targets: emerging opportunities","volume":"14","author":"Lin","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejps.2018.06.018_bb0130","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1101\/gad.266803","article-title":"Endothelial PDGF-B retention is required for proper investment of pericytes in the microvessel wall","volume":"17","author":"Lindblom","year":"2003","journal-title":"Genes Dev."},{"key":"10.1016\/j.ejps.2018.06.018_bb0135","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1124\/dmd.111.044420","article-title":"Use of the cassette-dosing approach to assess brain penetration in drug discovery","volume":"40","author":"Liu","year":"2012","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2018.06.018_bb0140","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1124\/dmd.113.055590","article-title":"Use of cassette dosing approach to examine the effects of P-glycoprotein on the brain and cerebrospinal fluid concentrations in wild-type and P-glycoprotein knockout rats","volume":"42","author":"Liu","year":"2014","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2018.06.018_bb0145","doi-asserted-by":"crossref","first-page":"8238","DOI":"10.1021\/jm5007935","article-title":"Rational use of plasma protein and tissue binding data in drug design","volume":"57","author":"Liu","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejps.2018.06.018_bb0150","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1021\/mp060082j","article-title":"Identification of influx transporter for the quinolone antibacterial agent levofloxacin","volume":"4","author":"Maeda","year":"2007","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2018.06.018_bb0155","first-page":"1","article-title":"ABC transporters at the blood\u2013brain barrier","author":"Mahringer","year":"2016","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.ejps.2018.06.018_bb0160","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/S1359-6446(04)03137-X","article-title":"Whatever happened to cassette-dosing pharmacokinetics?","volume":"9","author":"Manitpisitkul","year":"2004","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejps.2018.06.018_bb0165","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1111\/j.1476-5381.1996.tb15775.x","article-title":"Substantial excretion of digoxin via the intestinal mucosa and prevention of long-term digoxin accumulation in the brain by the mdr 1a P-glycoprotein","volume":"119","author":"Mayer","year":"1996","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejps.2018.06.018_bb0170","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1074\/jbc.R116.760215","article-title":"The translational significance of the neurovascular unit","volume":"292","author":"McConnell","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejps.2018.06.018_bb0175","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nrn2995","article-title":"Engaging neuroscience to advance translational research in brain barrier biology","volume":"12","author":"Neuwelt","year":"2011","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ejps.2018.06.018_bb0180","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1124\/dmd.108.022087","article-title":"Involvement of the pyrilamine transporter, a putative organic cation transporter, in blood\u2013brain barrier transport of oxycodone","volume":"36","author":"Okura","year":"2008","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2018.06.018_bb0185","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1124\/dmd.109.029454","article-title":"Functional characterization of mouse organic anion transporting peptide 1a4 in the uptake and efflux of drugs across the blood\u2013brain barrier","volume":"38","author":"Ose","year":"2010","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2018.06.018_bb0190","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/BF01059688","article-title":"Hepatic clearance of drugs. I. Theoretical considerations of a \u201cwell-stirred\u201d model and a \u201cparallel tube\u201d model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance","volume":"5","author":"Pang","year":"1977","journal-title":"J. Pharmacokinet. Biopharm."},{"key":"10.1016\/j.ejps.2018.06.018_bb0195","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.brainres.2015.07.005","article-title":"Regulation of ABC efflux transporters at blood\u2013brain barrier in health and neurological disorders","volume":"1628","author":"Qosa","year":"2015","journal-title":"Brain Res."},{"key":"10.1016\/j.ejps.2018.06.018_bb0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40262-012-0018-5","article-title":"The clinical relevance of plasma protein binding changes","volume":"52","author":"Roberts","year":"2013","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejps.2018.06.018_bb0205","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1111\/j.1476-5381.2011.01724.x","article-title":"OATPs, OATs and OCTs: the organic anion and cation transporters of the SLCO and SLC22A gene superfamilies","volume":"165","author":"Roth","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejps.2018.06.018_bb0210","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1002\/jps.22567","article-title":"Diphenhydramine active uptake at the blood\u2013brain barrier and its interaction with oxycodone in vitro and in vivo","volume":"100","author":"Sadiq","year":"2011","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2018.06.018_bb0215","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1038\/ncomms3932","article-title":"Pericyte loss influences Alzheimer-like neurodegeneration in mice","volume":"4","author":"Sagare","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejps.2018.06.018_bb0220","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1172\/JCI118214","article-title":"Absence of the mdr1a P-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A","volume":"96","author":"Schinkel","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejps.2018.06.018_bb0225","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/bpa.12004","article-title":"Deficiency in mural vascular cells coincides with blood\u2013brain barrier disruption in Alzheimer's disease","volume":"23","author":"Sengillo","year":"2013","journal-title":"Brain Pathol."},{"key":"10.1016\/j.ejps.2018.06.018_bb0230","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/jcbfm.2012.25","article-title":"Pathophysiology of the neurovascular unit: disease cause or consequence?","volume":"32","author":"Stanimirovic","year":"2012","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.ejps.2018.06.018_bb0235","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.0000052","article-title":"Additive effects of PDGF receptor beta signaling pathways in vascular smooth muscle cell development","volume":"1","author":"Tallquist","year":"2003","journal-title":"PLoS Biol."},{"key":"10.1016\/j.ejps.2018.06.018_bb0240","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1017\/S1461145704004390","article-title":"The brain entry of risperidone and 9-hydroxyrisperidone is greatly limited by P-glycoprotein","volume":"7","author":"Wang","year":"2004","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.ejps.2018.06.018_bb0245","first-page":"957","article-title":"Pharmacokinetic theory of cassette dosing in drug discovery screening","volume":"29","author":"White","year":"2001","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2018.06.018_bb0250","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1038\/nn.2946","article-title":"Central nervous system pericytes in health and disease","volume":"14","author":"Winkler","year":"2011","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ejps.2018.06.018_bb0255","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00401-012-1039-8","article-title":"Blood-spinal cord barrier breakdown and pericyte reductions in amyotrophic lateral sclerosis","volume":"125","author":"Winkler","year":"2013","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ejps.2018.06.018_bb0260","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.cell.2015.10.067","article-title":"Establishment and dysfunction of the blood\u2013brain barrier","volume":"163","author":"Zhao","year":"2015","journal-title":"Cell"}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098718302744?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098718302744?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,21]],"date-time":"2018-08-21T01:20:21Z","timestamp":1534814421000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098718302744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":52,"alternative-id":["S0928098718302744"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2018.06.018","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacokinetics of pericyte involvement in small-molecular drug transport across the blood-brain barrier","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2018.06.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}